Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
This grant funds efficient and innovative natural history studies that address unmet needs in rare diseases.
About this program
The Reissue of RFA-FD-22-001 grant aims to support research that enhances our understanding of rare diseases through natural history studies. These studies are crucial for identifying the progression of rare diseases, which can lead to better treatment options and improved patient outcomes. The grant is intended for researchers and institutions focused on rare diseases, providing them with the necessary funding to conduct comprehensive studies that fill existing knowledge gaps. Eligible applicants include academic institutions, nonprofit organizations, and other research entities that have the capability to conduct clinical trials. The grant encourages innovative approaches and methodologies that can lead to significant advancements in the field of rare diseases. By fostering collaboration among researchers, this grant aims to accelerate the development of effective interventions and therapies for patients suffering from these conditions.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and other research entities capable of conducting clinical trials.